Agenda

Download 2011 Summit Program JUMP TO : Monday, October 3 \| Tuesday, October 4 \| Wednesday, October 5 MONDAY, OCTOBER 3, 2011
12:00-7:00 P.M.	Registration Open
12:00 P.M.	Exhibits Open - Light Refreshments 2nd and 3rd Floors
2:00 P.M.	Welcome Delos Cosgrove, MD Chief Executive Officer and President Cleveland Clinic Thomas Graham, MD Chair, Innovations, Cleveland Clinic
2:15 P.M.	Cardiovascular Care's Most Pressing Challenges Bruce Lytle, MD Chair, Heart and Vascular Institute, Cleveland Clinic
	Perspectives from the Top of Industry Moderator: Maria Bartiromo, Anchor, CNBC Leaders of some of the most influential organizations in healthcare provide their unique outlook on the current challenges and strengths of the health care industry, the climate for innovation, where we are, and where we are headed.
	Ursula Burns, Chief Executive Officer, Xerox Delos Cosgrove, MD Harry Rein, General Partner, Foundation Medical Partners John Sheets, PhD, Senior Vice President, Corporate Research, Boston Scientific Daniel Starks, Chief Executive Officer, St. Jude Medical
3:45 P.M.	The 2012 Elections and its Effect on Innovation Moderator: Paul Begala, Political Analyst and Commentator, CNN and Columnist, Newsweek and The Daily Beast Rarely has medical innovation played such a central role in US elective politics. This bipartisan panel will discuss how healthcare innovation will play out in the 2012 election and beyond. Raymond Gilmartin, Harvard Business School Ezra Klein, Columnist, The Washington Post Gail Wilensky, PhD, Senior Fellow, Project HOPE
4:45 P.M.	The Grand Scientific Challenges in Cardiovascular Care A discussion on the key scientific challenges driving the world of cardiovascular care. Ferid, Murad, MD, PhD, Nobel Laureate and Professor, George Washington University
5:15 - 6:30 P.M.	Wine Tasting Welcome Reception
6:30 P.M.	Dinner: Founder's Ballroom Introduction: Delos Cosgrove, MD Moderator: Maria Bartiromo, Healthcare as a Pillar of Competitiveness Mr. Immelt will share how improving healthcare is central to future competitiveness. He will discuss the role of innovation in breaking through barriers of cost, quality and access and share his thoughts on sustaining healthcare and innovation in meaningful ways. His comments will be followed with a conversation with Maria Bartiromo. Jeffrey Immelt, Chairman and Chief Executive Officer, General Electric
TUESDAY, OCTOBER 4, 2011 Back to Top
7:00-2:00 P.M.	Registration Open
7:00-8:30 A.M.	Continental Breakfast
7:00-6:00 P.M.	Exhibits Open 2nd and 3rd Floors
7:00 A.M.	Welcome Chris Coburn Executive Director, Cleveland Clinic Innovations
7:00-8:00 A.M.	Procedural Demonstrations Moderators: Nicholas Smedira, MD, Cardiothoracic Surgery, Cleveland Clinic, Cleveland Clinic Murat Tuzcu, MD, Vice Chair, Cardiovascular Medicine, Cleveland Clinic Attendees will see the latest innovations in LVAD Implantation and Transcatheter Aortic Valve Replacements through discussion of case history, available treatment options, demonstrations of latest technologies used and a wrap up discussion amongst leading Cleveland Clinic physicians. Surgeons: Gonzalo Gonzales-Stawinski, MD, Thoracic and Cardiovascular Surgery, Cleveland Clinic Samir Kapadia, MD, Interventional Cardiology, Cleveland Clinic Lars Svensson, MD, PhD, Thoracic and Cardiovascular Surgery, Cleveland Clinic
8:00 -9:00 A.M.	The Shifting Cardiovascular Medical Device Environment Moderator:Roger Longman, Chief Executive Officer, Real Endpoints CEOs and executive leaders of the most important organizations in the cardiovascular device community, including the FDA, will discuss the state of device innovation and adoption. Bernard Lyons, PhD, Chief Executive Officer, Direct Flow Medical Michael Mussallem, Chief Executive Officer, Edwards Lifesciences Ferolyn Powell, Divisional Vice President & General Manager, Structural Heart, Abbott Vascular Murat Tuzcu, MD Bram Zuckerman, MD, Director, Division of Cardiovascular Devices, US, Food and Drug Administration
9:00-10:00 A.M.	The State of Cardiovascular Drug Development Moderator: Roger Longman, Leaders of the major pharmaceutical companies review the systematic breakthroughs in cardiovascular pharmacology and discuss how careful planning - not serendipity - has helped achieve significant advancements in the current treatment. Howard Hutchinson, MD, Chief Medical Officer, AstraZeneca Clive Meanwell, MD, PhD, Chief Executive Officer, The Medicines Company Steven Nissen, MD, Chair, Cardiovascular Medicine, Cleveland Clinic Michael Rosenblatt, MD, Chief Medical Officer, Merck John Smith, MD, PhD, Senior Vice President, Clinical Department and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.
10:00-10:15 A.M.	Break
10:15-11:15 A.M.	Treating the Heart Failure Patient: New Technology, New Promise Moderator: Robert Bazell, Chief Science and Health Correspondent, NBC Heart failure remains the largest single disease in all of healthcare- chief executives and top clinicians examine new breakthrough therapies currently under development. Gary Burbach, Chief Executive Officer, Thoratec Eric Fain, MD, President, Cardiac Rhythm Management Division, St. Jude Medical Douglas Godshall,Chief Executive Officer, Heartware Gonzalo Gonzalez-Stawinski, MD, Pat Mackin, Senior Vice President, Cardiac Rhythm Disease Management, Medtronic Randall Starling, MD, Head of Heart Failure and Cardiac Transplant Medicine, Cleveland Clinic
11:15 A.M. -12:15 P.M.	Peripheral Arterial Disease: New Innovations to Treat a Growing Cohort Moderator: Michelle Cortez, Bloomberg Peripheral Artrerial Disease is considered a largely unaddressed disease market mostly due to the special challenges of fighting cardiovascular disease in the periphery. Top leaders in the field discusses the prospect for new breakthroughs. Dan Clair, MD, Chair, Vascular Surgery, Cleveland Clinic Matthew Ferguson, Chief Business Officer, Avinger Robert "Chip" Hance, President, Abbott Vascular Tim Ring, Chief Executive Officer, CR Bard Campbell Rogers, MD,Chief Scientific Officer and Global Head, Research and Development, Cordis Corporation
12:15-1:35 P.M.	Lunch: Founder's Ballroom Partnering for Biomedical Innovation: Starting the Dialogue Ian Read, Chief Executive Officer, Pfizer Biomedical innovation has improved human life and created wealth in our society, but there are challenges to ongoing innovation in medicine. The talk will examine these challenges and create an opportunity to start a dialogue among healthcare providers across the industry to evaluate how, together, we can earn the respect of society, alter policies to support ongoing medical innovation, and collaborate to create more efficient ways to treat patients.
1:40-2:40 P.M.	Cardiovascular Investing: Compelling Opportunities or Aging Grand Dame? Moderator: Roger Longman Do investment opportunities in cardiovascular technology still provide sufficient return potential after more than half a century of active venture investing? Reinhard Ambros, PhD, Executive Director and Head, Novartis Venture Funds Mike Buck, Divisional Vice President, Abbott Ventures Marc Gillinov, MD, Thoracic and Cardiovascular Surgery, Cleveland Clinic John Maroney, General Partner, Delphi Ventures Jason Mills, Managing Director, Equity Research, Medical Devices, Canaccord Genuity Antoine Papiernik, Managing Partner, Sofinnova
2:40 - 3:45 P.M.	Ensuring the Innovation Balance: White Oak vs. Brussels Moderator: Robert Bazell The chief leaders of the three principle industry associations and one of the Clinic's top surgeons will discuss the state of regulatory approval in the US and perceptions about greater flexibility in overseas markets. John Castellani, Chief Executive Officer, PhRMA Roy Greenberg, MD, Vascular Surgery, Cleveland Clinic James Greenwood, Chief Executive Officer, BIO Stephen Ubl, President, AdvaMed
3:45-4:15 P.M.	Keynote Address: Revitalizing a Market-Leading Cardiac Franchise in a Time of Economic Challenge Moderator: Michelle Cortez Omar Ishrak, Chief Executive Officer, Medtronic At a time when economic challenges and healthcare reform are impacting patients, payers, healthcare providers and device manufacturers alike, it is critical for stakeholders across the treatment continuum to work together to find solutions that improve efficiencies and reduce the cost of healthcare - all while delivering better therapeutic options to patients and their physicians. Mr. Ishrak will explore the significant unmet clinical needs that patients and their physicians face, and will make the case for why technology combined with an increased focus on economic value can revitalize the cardiac franchise.
4:15-4:30 P.M.	Break
4:30-5:15 P.M.	Beyond Jeopardy! The Implications of IBM's Watson Watson was built to rival human's ability to answer questions posed in natural language with speed, accuracy and confidence. The system passed its first test on Jeopardy!, beating the show's two greatest champions, but the real test will be in applying the underlying data management and analytics technology across industries like healthcare. Join us to see two of Cleveland Clinic's top cardiovascular clinicians challenge Watson and learn about future implications. Introduction: David Ferrucci, PhD, Principal Investigator, DeepQA/Watson Project, IBM Research Challenge Host: David Shepler, Jeopardy Challenge Program Manager, IBM Marc Gillinov, MD Steve Nissen, MD Watson, IBM
5:15-6:15 P.M.	Breakout Sessions Concurrent sessions will be held to allow a deep dive into cutting edge cardiovascular issues. - Cardiovascular's Special Regulatory Challenges Moderator: Howard Holstein, Partner, Hogan Lovells US LLP A top regulatory consultant will moderate a focused discussion between venture capitalists, a top FDA leader and the head of Cleveland Clinic's clinical trial center on pending regulatory changes and their impact on the cardiovascular regulatory landscape. Jan Garfinkle, Managing Partner, Arboretum Ventures Michael Lincoff, MD, Vice Chairman, Cardiovascular Medicine, Cleveland Clinic William Maisel, MD, Deputy Center Director, Sciences and CDRH Chief Scientist, U.S. Food and Drug Administration Rebecca Robertson, Managing Director, Versant Ventures - Regenerative Medicine: Is the Dream Becoming a Reality? Moderator: Stephen Ellis, MD, Invasive / Interventional Cardiology, Cleveland Clinic Top Executives of leading edge companies give their unique and upbeat perspectives on how regenerative medicine to treat the cardiovascular disease is a short step away from reality. Rahul Aras, PhD, Chief Executive Officer, Juventas Therapeutics Andrea Hunt, Vice President Regenerative Medicine, Baxter Healthcare William Lehman, President and Chief Operating Officer, Athersys - Watson in Everyday Clinical Decision Making Moderator: Roger Longman The specifics of how systems like Watson will be put into daily use will be examined by IBM team leaders and two highly IT savvy Cleveland Clinic clinicians. Basit Chaudhry, MD, PhD, Senior Researcher, Clinical Transformation, Healthcare Analytics, IBM Research David Ferrucci, PhD Doug Johnston, MD, Staff Cardiac Surgeon, Cleveland Clinic William Morris, MD, Associate Staff Hospital Medicine, Cleveland Clinic - Reimbursement: Innovation's Inner Self Moderator: Carol Harding, Senior Director, Supply Chain Innovations, Cleveland Clinic Reimbursement considerations are now core to the devlopment of any new product innovation. This session will examine reimbursement of new cardiovascular technologies from the patient, provider, company and government perspective. Moderator: Carol Harding, Senior Director Supply Chain Innovations, Cleveland Clinic Jeffrey Gruen, MD, Partner, PricewaterhouseCoopers Bonnie Handke, Senior Director Reimbursement, Medtronic Sean Lyden, MD, Vascular Surgery, Cleveland Clinic Gwen Mayes, Executive Vice President, National Patient Advocate Foundation Jake Orville, Chief Executive Officer, Cleveland HeartLab - Tour of Cleveland Clinic's Global Cardiovascular Innovation Center (GCIC) GCIC Provides a state-of-the-art home for medical technology companies in all fields. Designed, built and equipped as one of the fist cardiovascular healthcare focused incubators in the U.S., GCIC delivers 50,000 square feet of prime, brand new space.
6:30-9:00 P.M.	Sunset Dinner Gala & Fireworks Display on the Lake Erie Shore The Shorby Club
WEDNESDAY, OCTOBER 5, 2011 Back to Top
7:00-9:00 A.M.	Registration Open
7:00-8:30 A.M.	Continental Breakfast
7:00-12:00 P.M.	Exhibits Open 2nd and 3rd Floors
7:30-8:30 A.M.	Procedural Demonstrations Moderators: Matthew Eagleton, MD, Vascular Surgery, Cleveland Clinic Bruce Lindsay, MD, Chair, Electrophysiology, Cleveland Clinic Attendees will see the latest innovations in Electrophysiology and Peripheral Arteral Disease Treatments for treating a variety of atrial and ventricular fibrillation and lower extremity disease. Case histories, available treatment options, demonstrations of latest technologies and a wrap up discussion amongst leading Cleveland Clinic physicians will provide a clear picture of where this rapidly changing field is going. . Surgeons: Daniel Clair, MD Mohamed Kanj, MD, Electophysiology, Cleveland Clinic Sean Lyden, MD Walid Saliba, MD, Electrophysiology, Cleveland Clinic Sunita Srivastava, MD, Vascular Surgery, Cleveland Clinic Oussama Wazni, MD, Electophysiology, Cleveland Clinic
8:30-9:10 A.M.	The Case for Smarter Medicine David Snow, Chief Executive Officer, Medco Moderator: Michelle Cortez The prospects for genuine, sustainable healthcare reform will hinge upon the extent to which innovation, including health information technology, is embraced and implemented system wide. Mr. Snow will make the case that a truly "wired" healthcare system - the sort already established in the world of advanced pharmacy - has the potential to address issues of medication non-compliance, patient safety and significant missions in care, leading the way from the current approach of "shotgun medicine" to a new world of precision medicine that can form the foundation for sustainable healthcare reform.
9:10-10:10 A.M.	Breakthroughs in Cardiovascular Imaging: Powerful New Insights; Strong Cost Pressures Moderator: Michelle Cortez Clinicians walk a fine line between reliance on ever-improving imaging technology and the cost of acquiring the added information. Join the debate with clinicians and industry executives as they calibrate these trade-offs and the future of cardiovascular imaging. Rory Hachamovitch, MD, Cardiovascular Imaging, Cleveland Clinic Douglas Hansell, MD, Medical Director, Medical & Clinical Affairs, GE Healthcare Scott Huennekens, Chief Executive Officer, Volcano Tom Marwick, MD, PhD, Cardiovascular Imaging, Cleveland Clinic Bert van Meurs, General Manager, Interventional X-Ray, Philips Healthcare
10:10-10:30 A.M.	Break
10:30-11:30 A.M.	Investing Health Care IT: The Hottest Market in the Industry Moderator: Vi Schaffer, Research Vice President, Healthcare Providers, Gartner, Inc. IT is the hottest market in healthcare. Join these leading experts to discuss investment perspectives and hot new cardiovascular related IT technologies. Pat Fortune, PhD, Partner, Millennia Partners Martin Harris, MD, Chief Information Officer, Cleveland Clinic Mark Kvamme, Chief Investment Officer, JobsOhio Stephen McHale, Chief Executive Officer, Explorys John Reardon, Managing Partner, Trident Capital
11:30 -12:30 P.M.	Top 10 Medical Innovations for 2012 Moderator: Michael Roizen, MD, Chief Wellness Officer, Cleveland Clinic Cleveland Clinic's Top 10 list of breakthrough technologies for the coming year has become an international sensation. Join us again as Dr. Mike Roizen and a panel of ten of the Clinic's physician leaders roll out these much anticipated selections.
12:30-2:00 P.M.	Lunch: Founder's Ballroom A Patient's Perspective on Cardiovascular Innovation Moderator: Bob Woodruff, ABC News Anchor At its most fundamental level, all innovation is about the patient. Please join us for a powerful exchange with one of the nation's best known heart failure patients. The session will include one of the Clinic's leading cardiac surgeons. Clinical Lead: Nicholas Smedira, MD Dick Cheney, Former US Vice President Medicare's Innovation Agenga: What's possible, what's likely and what will it mean to me? One of the most significant actions taken during this period of health care reform was the establishment of the Center for Medicaid and Medicare Innovation at CMS. The leader of the center will discuss his perspectives on health care innovation and the role of the world's largest payor. Richard Gilfillan, MD, Acting Director, Center for Medicaid and Medicare Innovation
2:00 - 2:15 P.M.	Wrap-Up and Adjournment Joseph Hahn, MD, Chief of Staff, Cleveland Clinic